Conference
Potential Impact of Pathologic Review on Therapy in Non-Hodgkin's Lymphoma (NHL): Analysis from the National Comprehensive Cancer Network (NCCN) NHL Outcomes Project.
Abstract
Abstract
Background: Optimal therapy of NHL is critically dependent upon an accurate pathologic diagnosis. High inter-rater reliability has been demonstrated among expert hematopathologists for common B cell NHLs using the WHO classification system. However, less is known about the accuracy and reliability of pathologic diagnosis of lymphoma in the routine care setting.
Authors
LaCasce A; Niland J; Kho ME; terVeer A; Friedberg JW; Rodriguez MA; Czuczman MS; Millenson M; Zelenetz AD; Nademanee AP
Volume
106
Publisher
American Society of Hematology
Publication Date
November 16, 2005
DOI
10.1182/blood.v106.11.2816.2816
Conference proceedings
Blood
Issue
11
ISSN
0006-4971